Literature DB >> 33786756

Birth prevalence of congenital anomalies in Argentina, according to socioeconomic level.

Ruben Bronberg1,2,3, Boris Groisman4,5, Maria Paz Bidondo4,6, Pablo Barbero4, Rosa Liascovich4,5.   

Abstract

Birth prevalence of congenital anomalies (CA) in Argentina is estimated around 1.7%. CA are the second leading cause of infant mortality. Poverty and other adverse socioeconomic conditions have been associated with birth defects. To describe the prevalence at birth of CA, according to the two proxy variables of socioeconomic level: the health subsector of the hospital where the cases were born (PUB-public versus PRI-private or social security) and its geographical location. The design of the study was ecological using the data of the National Network of Congenital Anomalies of Argentina (RENAC); from October 2010 to December 2018. CA birth prevalence was estimated using the Poisson regression. We used a logistic regression model to analyze the association birth prevalence to health subsector and geographical region. A total of 2,202,994 births were examined in the study period, with a global CA prevalence of 1.69% (95% CI 1.68-1.71). The highest prevalence was observed in PUB hospitals when comparing to PRI hospitals at the country level and in all regions. There were differences in the prevalence of selected congenital anomalies with a statistically significant association to PUB (observed in anencephaly, encephalocele, hydrocephalus, microcephaly, holoprosencephaly, microtia/anotia, cleft lip and palate, postaxial polydactyly, talipes equinovarus, talipes calcaneovalgus, and gastroschisis). The prevalence of critical heart defects and chromosomal anomalies was significantly higher in PRI hospitals. Although this is an ecological study with no information on socioeconomic status at individual level, we found an association between CA frequency and selected CA with the PUB subsector. Vulnerable populations affected with CA require a greater effort from policy makers and health care providers to allocate more resources and design strategies to access to health.

Entities:  

Keywords:  Argentina; Birth defects; Socioeconomic status

Year:  2021        PMID: 33786756     DOI: 10.1007/s12687-021-00516-5

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  4 in total

Review 1.  Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.

Authors:  Silvia Baldacci; Francesca Gorini; Michele Santoro; Anna Pierini; Fabrizio Minichilli; Fabrizio Bianchi
Journal:  Epidemiol Prev       Date:  2018 May-Aug       Impact factor: 1.901

2.  Microtia-anotia: a global review of prevalence rates.

Authors:  Daniela Varela Luquetti; Emanuele Leoncini; Pierpaolo Mastroiacovo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-06-07

3.  [Anencephaly related infant mortality in Argentina: spatial and temporal analysis (1998-2007)].

Authors:  Rubén Bronberg; Emma Alfaro; Estela Chaves; Alberto Andrade; Juan Gili; Jorge López Camelo; José Dipierri
Journal:  Arch Argent Pediatr       Date:  2011-04       Impact factor: 0.635

4.  Prenatal detection of congenital anomalies and related factors in Argentina.

Authors:  Maria Paz Bidondo; Boris Groisman; Santiago Duarte; Agostina Tardivo; Rosa Liascovich; Pablo Barbero
Journal:  J Community Genet       Date:  2020-01-03
  4 in total
  2 in total

1.  Prevalence of Congenital Anomaly and Its Relationship with Maternal Education and Age According to Local Development in the Extreme South of Brazil.

Authors:  Carolina Ribeiro Anele; Marcelo Zubaran Goldani; Lavínia Schüler-Faccini; Clécio Homrich da Silva
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

2.  Current Challenges in the Treatment of the Omphalocele-Experience of a Tertiary Center from Romania.

Authors:  Elena Ţarcă; Elena Cojocaru; Laura Mihaela Trandafir; Alina Costina Luca; Răzvan Călin Tiutiucă; Lăcrămioara Ionela Butnariu; Claudia Florida Costea; Iulian Radu; Mihaela Moscalu; Viorel Ţarcă
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.